Acumen Pharmaceuticals, Inc. (ABOS) Stock Price History
Historical prices from 2021 to 2026
Loading 10-year price history...
ABOS Historical Performance
Short-Term Returns
ABOS Stock Price Trajectory (2021–2026)
As of May 8, 2026, Acumen Pharmaceuticals, Inc. (ABOS) trades at $2.47, representing a +147.9% return over the past year. The stock has delivered a -87.7% total return over five years (-34.2% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $26.98 on July 1, 2021. From this peak, ABOS has corrected -90.8%, currently trading 18% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers PRAX (+775.0% 1Y), ATNM (-12.9% 1Y), and SAVA (+25.3% 1Y), ABOS has underperformed the peer group average. Compare ABOS vs PRAX →
ABOS Historical Price Data (2025–2026)
Showing 30 of 1,219 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 2.54 | 2.58 | 2.40 | 2.47 | 325K | -3.89% |
| 2026-05-06 | 2.57 | 2.62 | 2.52 | 2.57 | 256K | +1.98% |
| 2026-05-05 | 2.50 | 2.55 | 2.47 | 2.52 | 255K | +1.61% |
| 2026-05-04 | 2.39 | 2.52 | 2.38 | 2.48 | 180K | +4.20% |
| 2026-05-01 | 2.36 | 2.44 | 2.35 | 2.38 | 159K | -0.42% |
| 2026-04-30 | 2.35 | 2.44 | 2.33 | 2.39 | 221K | +2.14% |
| 2026-04-29 | 2.43 | 2.44 | 2.33 | 2.34 | 270K | -4.88% |
| 2026-04-28 | 2.51 | 2.54 | 2.46 | 2.46 | 256K | -2.38% |
| 2026-04-27 | 2.62 | 2.69 | 2.50 | 2.52 | 331K | -1.95% |
| 2026-04-24 | 2.66 | 2.66 | 2.54 | 2.57 | 494K | -3.75% |
| 2026-04-23 | 2.79 | 2.88 | 2.67 | 2.67 | 298K | -4.98% |
| 2026-04-22 | 2.76 | 2.86 | 2.76 | 2.81 | 309K | +2.93% |
| 2026-04-21 | 2.88 | 2.88 | 2.72 | 2.73 | 274K | -3.87% |
| 2026-04-20 | 2.83 | 2.99 | 2.83 | 2.84 | 297K | +0.71% |
| 2026-04-17 | 2.78 | 2.90 | 2.77 | 2.82 | 441K | +4.83% |
| 2026-04-16 | 2.73 | 2.74 | 2.65 | 2.69 | 326K | -1.10% |
| 2026-04-15 | 2.68 | 2.74 | 2.63 | 2.72 | 337K | +1.49% |
| 2026-04-14 | 2.56 | 2.72 | 2.55 | 2.68 | 383K | +6.77% |
| 2026-04-13 | 2.46 | 2.63 | 2.45 | 2.51 | 464K | +1.62% |
| 2026-04-10 | 2.52 | 2.55 | 2.46 | 2.47 | 257K | -1.59% |
| 2026-04-09 | 2.57 | 2.67 | 2.50 | 2.51 | 509K | -2.71% |
| 2026-04-08 | 2.75 | 2.76 | 2.54 | 2.58 | 375K | -1.90% |
| 2026-04-07 | 2.71 | 2.71 | 2.48 | 2.63 | 759K | -4.71% |
| 2026-04-06 | 2.72 | 2.81 | 2.67 | 2.76 | 538K | +2.22% |
| 2026-04-02 | 2.49 | 2.75 | 2.49 | 2.70 | 635K | +5.88% |
| 2026-04-01 | 2.38 | 2.63 | 2.38 | 2.55 | 764K | +8.05% |
| 2026-03-31 | 2.19 | 2.42 | 2.19 | 2.36 | 381K | +7.76% |
| 2026-03-30 | 2.28 | 2.32 | 2.17 | 2.19 | 446K | -3.10% |
| 2026-03-27 | 2.48 | 2.55 | 2.25 | 2.26 | 919K | -11.37% |
| 2026-03-26 | 2.56 | 2.75 | 2.36 | 2.55 | 713K | -3.04% |
See ABOS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ABOS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ABOS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonABOS — Frequently Asked Questions
Quick answers to the most common questions about buying ABOS stock.
How has ABOS stock performed recently?
ABOS returned +147.9% over the past year, beating its 5-year annualized CAGR of -34.2%. The stock trades above its 200-day moving average, confirming the uptrend.
What is ABOS's all-time high price?
Acumen Pharmaceuticals, Inc. reached $26.98 on 2021-07-01. The 52-week high is $3.60. Current 1-year return of +147.9% places the stock closer to historical peaks.
Where can I download ABOS historical price data?
This page provides ABOS daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2021-2026, downloadable in CSV format.